chr19-39866960-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_003890.3(FCGBP):c.12149C>T(p.Ser4050Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,367,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )
Consequence
FCGBP
NM_003890.3 missense
NM_003890.3 missense
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.764
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.17).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGBP | NM_003890.3 | c.12149C>T | p.Ser4050Phe | missense_variant | 34/36 | NP_003881.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGBP | ENST00000616721.6 | c.12110C>T | p.Ser4037Phe | missense_variant | 26/28 | 1 | ENSP00000481056.3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152266Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152266
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251152Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135730
GnomAD3 exomes
AF:
AC:
5
AN:
251152
Hom.:
AF XY:
AC XY:
3
AN XY:
135730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000823 AC: 10AN: 1215558Hom.: 0 Cov.: 32 AF XY: 0.00000830 AC XY: 5AN XY: 602430
GnomAD4 exome
AF:
AC:
10
AN:
1215558
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
602430
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152384Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74516
GnomAD4 genome
AF:
AC:
10
AN:
152384
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74516
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.15713C>T (p.S5238F) alteration is located in exon 34 (coding exon 34) of the FCGBP gene. This alteration results from a C to T substitution at nucleotide position 15713, causing the serine (S) at amino acid position 5238 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at